Molecular epidemiology of vancomycin-resistant enterococci from 6 hospitals in New York State

American Journal of Infection Control

Volumn 27, Issue 5, 1999, Pages 411-417

  Bopp, Lawrence H ^a   Schoonmaker, Dianna J ^b   Baltch, Aldona L ^c   Smith, Raymond P ^c   Ritz, William J ^c  

^a The University of Southern Mississippi   (United States)

^b WADSWORTH CENTER   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA DNA HYBRIDIZATION; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; GENETIC HETEROGENEITY; HOSPITAL INFECTION; INFECTION CONTROL; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; UNITED STATES;

EID: 0032861002     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(99)70007-6     Document Type: Article

References (41)

1. 1. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
2. 2. Uttley AHC, George RC, Naidoo J, Woodford N, Johnson P, Collins CH, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989;103:173-81.
3. 3. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993, MMWR Morb Mortal Wkly Rep 1993;42:597-9.
4. 4. Moellering RC Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992;14:1173-8.
5. 5. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(Suppl 3B):72S-75S.
6. 6. Cross JT, Jacobs RF. Vancomycin-resistant enterococcal infections. Semin Pediatr Infect Dis 1996;7:162-9.
7. 7. Fraimow HS, Venuti E. Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1992;36:1563-6.
8. 8. Hayden MK, Koenig GI, Trenholme GM. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations. Antimicrob Agents Chemother 1994;38:1225-9.
9. 9. Landman D, Quale JM. Management of infections due to resistant enterococci: a review of therapeutic options. J Antimicrob Chemother 1997;40:161-70.
10. 10. Mobarakai N, Landman D, Quale JM. In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium. J Antimicrob Chemother 1994;33:319-21.
11. 11. Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997;24:545-56.
12. 12. Beezhold DW, Slaughter S, Hayden MK, Matushek M, Nathan C, Trenholme GM, et al. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis 1996;24:704-6.
13. 13. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1994;20:296-301.
14. 14. Biavesco F, Miele A, Vignaaroli C, Manso E, Lupidi R, Varaldo PE. Genotypic characterization of a nosocomial outbreak of vanA Enterococcus faecalis. Microb Drug Resist 1996;2:231-7.
15. 15. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-5.
16. 16. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994;34:515-28.
17. 17. Korten V, Murray BE. The nosocomial transmission of enterococci. Curr Opin Infect Dis 1993;6:498-505.
18. 18. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, et al. Outbreak of vancomycin-, ampicillin-, and amino-glycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363-7.
19. 19. Pegues DA, Pegues CF, Hibberd PA, Ford DS, Hooper DC. Emergence and discrimination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol 1997;35:1565-70.
20. 20. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from U. S. hospitals. Antimicrob Agents Chemother 1993;37:2311-7.
21. 21. Jones RN, Sader HS, Erwin ME, Anderson SC, the Enterococcus study group. Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United States. Diagn Microbiol Infect Dis 1995;21:85-93.
22. 22. Tenover FC. Laboratory methods for surveillance of vancomycin-resistant enterococci. Clin Microbiol Lett 1998;20:1-6.
23. 23. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;23:119-22.
24. 24. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved standard M7-A3, Villanova (PA): National Committee for Clinical Laboratory Standards; 1993.
25. 25. Smith CL, Cantor CR. Purification, specific fragmentation, and separation of large DNA molecules. Methods Enzymol 1987;155:449-67.
26. 26. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990;28:2059-63.
27. 27. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Pershing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
28. 28. Dice LR. Measures of the amount of ecologic association between species. Ecology 1945;26:297-302.
29. 29. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. The vanA 'glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes. Mol Gen Genet 1990;224:364-72.
30. 30. Evers S, Sahm DS, Courvalin P. Sequence of the vanB and dál genes encoding D-alanine:D-lactate and D-alanine:D-alanine ligases in vancomycin-resistant Enterococcus faecalis V583. Gene 1994;140:97-102.
31. 31. Handwerger S, Pucci MJ, Kolokathis A. Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228. Antimicrob Agents Chemother 1990;34:358-60.
32. 32. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1989.
33. 33. Pelts DN, Noble WC, Howell SA. Potential for gene transfer among enterococci from a single patient and the possibility of confounding typing results. J Clin Microbiol 1997;35:1722-7.
34. 34. Schoonmaker DJ, Bopp LH, Baltch AL, Smith RP, Rafferty ME, George M. Genetic analysis of multiple vancomycin-resistant Enterococcus isolates obtained serially from two long-term care patients. J Clin Microbiol 1998;36:2105-8.
35. 35. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene 1992;112:53-8.
36. 36. Navarro F, Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 1994;38:1788-93.
37. 37. Perichon B, Reynolds P, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997;41:2016-8.
38. 38. Woodford N, Adebiyi A-MM, Palepou M-FI, Cookson BD. Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother 1998;42:502-8.
39. 39. Handwerger S, Skoble J. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1995;39:2446-53.
40. 40. Clewell DB, Flanagan SE. The conjugative transposons of gram-positive bacteria. In: Clewell DB, editor. Bacterial conjugation. New York: Plenum Press; 1993.
41. 41. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. AJIC Am J Infect Control 1995;23:87-94.